Federal Patent Court

German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker

Retrieved on: 
Tuesday, May 7, 2024
Technology, Research, Genetics, Nanotechnology, Biotechnology, Health, Pharmaceutical, Other Science, Science, Corporation, UPC, BRKR, NanoString Technologies, RNA, Federal Patent Court (Germany), SMI, Patent, Court, Acquisition, Genomics, Federal Patent Court

Bruker Corporation (Nasdaq: BRKR) today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No.
  • NanoString is now a Bruker business following Bruker’s asset acquisition of the businesses of NanoString Technologies, Inc on May 6th, 2024.
  • The 928 Patent has been asserted by 10x Genomics against NanoString in patent infringement cases in Germany and before the European Unified Patent Court (UPC) involving NanoString’s CosMx Spatial Molecular Imager (SMI) products for RNA detection.
  • The Federal Patent Court ruled that the German part of the 928 Patent is invalid.

Bound2B successfully obtains preliminary injunction against Xolution Germany GmbH and its re-sealable XO closing device on beverage cans

Retrieved on: 
Thursday, March 21, 2024
Federal Patent Court, District court, Injunction, XO, Judgement, European Patent Convention, Patent, EP, Court

RHENEN, Netherlands, March 21, 2024 /PRNewswire/ -- Bound2B B.V., the creator and owner of several resealable beverage can patents and technologies in Europe and the US, today announced that it has successfully obtained a preliminary injunction against Xolution Germany GmbH.  The decision was issued by the District Court of Düsseldorf, Germany, and follows infringement proceedings filed by Bound2B against Xolution GmbH.

Key Points: 
  • in particular its XO closing device, in Germany
    RHENEN, Netherlands, March 21, 2024 /PRNewswire/ -- Bound2B B.V., the creator and owner of several resealable beverage can patents and technologies in Europe and the US, today announced that it has successfully obtained a preliminary injunction against Xolution Germany GmbH.
  • The decision was issued by the District Court of Düsseldorf, Germany, and follows infringement proceedings filed by Bound2B against Xolution GmbH.
  • In 2020, Bound2B initiated patent infringement proceedings before the District Court of Düsseldorf based on EP 930 against Xolution GmbH, who manufactured, advertised, and delivered the XO closing device.
  • In order to prevent further offering and selling of the XO closing device in Germany, Bound2B filed for urgent proceedings and asked the Düsseldorf Court to immediately issue a preliminary injunction against Xolution Germany GmbH as well as its Managing Director, Mr. von Rettberg.

Bound2B successfully obtains preliminary injunction against Xolution Germany GmbH and its re-sealable XO closing device on beverage cans

Retrieved on: 
Thursday, March 21, 2024
Federal Patent Court, District court, Injunction, XO, Judgement, European Patent Convention, Patent, EP, Court

RHENEN, Netherlands, March 21, 2024 /PRNewswire/ -- Bound2B B.V., the creator and owner of several resealable beverage can patents and technologies in Europe and the US, today announced that it has successfully obtained a preliminary injunction against Xolution Germany GmbH.  The decision was issued by the District Court of Düsseldorf, Germany, and follows infringement proceedings filed by Bound2B against Xolution GmbH.

Key Points: 
  • in particular its XO closing device, in Germany
    RHENEN, Netherlands, March 21, 2024 /PRNewswire/ -- Bound2B B.V., the creator and owner of several resealable beverage can patents and technologies in Europe and the US, today announced that it has successfully obtained a preliminary injunction against Xolution Germany GmbH.
  • The decision was issued by the District Court of Düsseldorf, Germany, and follows infringement proceedings filed by Bound2B against Xolution GmbH.
  • In 2020, Bound2B initiated patent infringement proceedings before the District Court of Düsseldorf based on EP 930 against Xolution GmbH, who manufactured, advertised, and delivered the XO closing device.
  • In order to prevent further offering and selling of the XO closing device in Germany, Bound2B filed for urgent proceedings and asked the Düsseldorf Court to immediately issue a preliminary injunction against Xolution Germany GmbH as well as its Managing Director, Mr. von Rettberg.

NanoString Responds to Decision of the Regional Court of Munich

Retrieved on: 
Wednesday, May 17, 2023
Professional Services, Health, Legal, Genetics, Research, Science, Biotechnology, Palatine Higher Regional Court, NanoString Technologies, Genomics, Federal Patent Court (Germany), SMI, Harvard College, RNA, Harvard University, Protein, Patent, Fellows, Sąd rejonowy, Federal Patent Court, Synovial joint

The Munich court granted 10x Genomics, Inc. and President and Fellows of Harvard College the right to enforce an injunction against use of the CosMx SMI instrument for RNA detection in Germany.

Key Points: 
  • The Munich court granted 10x Genomics, Inc. and President and Fellows of Harvard College the right to enforce an injunction against use of the CosMx SMI instrument for RNA detection in Germany.
  • NanoString believes the Munich court came to an erroneous conclusion and will appeal the decision.
  • In addition, the decision does not apply to the use of the CosMx SMI instrument for detection of proteins, which NanoString will continue to offer and support.
  • “We respectfully disagree with the recent decision of the Regional Court of Munich,” said Brad Gray, President and CEO of NanoString.

CommScope Patents Upheld by German Federal Patent Court

Retrieved on: 
Wednesday, October 16, 2019
Telecommunications, Networks, Internet, Hardware, Data management, Technology, Mobile, Wireless, Other Technology, Law by country, Law, Intellectual property law, European Patent Organisation, Business law, Patent law, Patent, European Patent Convention, Federal Patent Court, Unitary patent, Patent attorney

The German Federal Patent Court has issued decisions upholding the validity of important CommScope patents that had been challenged by a competitor, COMLAB.

Key Points: 
  • The German Federal Patent Court has issued decisions upholding the validity of important CommScope patents that had been challenged by a competitor, COMLAB.
  • At an October 9 oral hearing, the German Federal Patent Court rejected challenges by COMLAB regarding the validity of the German part of European Patent EP1022849B1 (Action No.
  • The Federal Patent Court already upheld the German part of European Patent EP2180605B1 in a decision dated March 27, 2019 (Action No.
  • COMLAB attempted to challenge the validity of both patents, but the October 9 decision by the German Federal Patent Court has now upheld both patents.